R. Siegel, J. Ma, Z. Zou, and A. Jemal, Cancer statistics, CA Cancer J Clin. févr, vol.64, issue.1, pp.9-29, 2014.

F. Barlesi, J. Mazieres, J. Merlio, D. Debieuvre, J. Mosser et al., Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), Lancet. 2 avr, vol.387, pp.1415-1441, 2016.

M. E. Froudarakis, J. Plojoux, E. Kaspi, S. Anevlavis, S. Laroumagne et al., Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions, Clin Respir J. 28 févr, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02000328

R. Thomas, R. Francis, H. E. Davies, and Y. Lee, Interventional therapies for malignant pleural effusions: the present and the future, Respirology. août, vol.19, issue.6, pp.809-831, 2014.

M. E. Roberts, E. Neville, R. G. Berrisford, G. Antunes, and N. J. Ali, BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline, Thorax. août, vol.65, issue.2, pp.32-40, 2010.

J. M. Porcel, A. Gasol, S. Bielsa, C. Civit, R. W. Light et al., Clinical features and survival of lung cancer patients with pleural effusions, Respirology. mai, vol.20, issue.4, pp.654-663, 2015.

A. O. Clive, B. C. Kahan, C. E. Hooper, R. Bhatnagar, A. J. Morley et al., Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score, Thorax. déc, vol.69, issue.12, pp.1098-104, 2014.

A. C. Bibby, P. Dorn, I. Psallidas, J. M. Porcel, J. Janssen et al., ERS/EACTS statement on the management of malignant pleural effusions, Eur Respir J. juill, vol.52, issue.1, 2018.

H. E. Davies and Y. Lee, Management of malignant pleural effusions: questions that need answers, Curr Opin Pulm Med. juill, vol.19, issue.4, pp.374-383, 2013.

J. M. Porcel, M. Lui, A. D. Lerner, H. E. Davies, D. Feller-kopman et al., Comparing approaches to the management of malignant pleural effusions, Expert Rev Respir Med, vol.11, issue.4, pp.273-84, 2017.

R. Myers and G. Michaud, Tunneled pleural catheters: an update for 2013, Clin Chest Med. mars, vol.34, issue.1, pp.73-80, 2013.

A. O. Clive, H. E. Jones, R. Bhatnagar, N. J. Preston, and N. Maskell, Interventions for the management of malignant pleural effusions: a network meta-analysis, Cochrane Database Syst Rev. 8 mai, issue.5, p.10529, 2016.

S. Bielsa, P. Hernández, F. Rodriguez-panadero, T. Taberner, A. Salud et al., Tumor type influences the effectiveness of pleurodesis in malignant effusions, Respiration, vol.189, issue.2, pp.91-99, 2011.

S. Mummadi, A. Kumbam, and P. Y. Hahn, Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis, vol.3, p.254, 2014.

C. M. Dresler, J. Olak, J. E. Herndon, W. G. Richards, E. Scalzetti et al., Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion, Chest. mars, vol.127, issue.3, pp.909-924, 2005.

R. Bhatnagar, M. Laskawiec-szkonter, H. Piotrowska, B. C. Kahan, C. E. Hooper et al., Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial, BMJ Open, vol.4, issue.11, p.7045, 2014.

W. H. Warren, A. W. Kim, and M. J. Liptay, Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion, Eur J Cardiothorac Surg. janv, vol.33, issue.1, pp.89-94, 2008.

A. Tremblay and G. Michaud, Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion, Chest. févr, vol.129, issue.2, pp.362-370, 2006.

H. E. Davies, E. K. Mishra, B. C. Kahan, J. M. Wrightson, A. E. Stanton et al., Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial, JAMA. 13 juin, vol.307, issue.22, pp.2383-2392, 2012.

R. Thomas, E. Fysh, N. A. Smith, P. Lee, B. Kwan et al., Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial, JAMA, vol.21, pp.1903-1915, 2017.

B. M. Machiels, A. H. Zorenc, J. M. Endert, H. J. Kuijpers, G. J. Van-eys et al., An alternative splicing product of the lamin A/C gene lacks exon 10, J Biol Chem. 19 avr, vol.271, issue.16, pp.9249-53, 1996.

F. Lin and H. J. Worman, Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C, J Biol Chem. 5 août, vol.268, issue.22, pp.16321-16327, 1993.

T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker et al., Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin, Genes Dev. 1 avr, vol.22, issue.7, pp.832-53, 2008.

P. Cau, C. Navarro, K. Harhouri, P. Roll, S. Sigaudy et al., Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective, Semin Cell Dev Biol. mai, vol.29, pp.125-172, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01646524

J. Broers, F. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison, Nuclear lamins: laminopathies and their role in premature ageing, Physiol Rev. juill, vol.86, issue.3, pp.967-1008, 2006.

J. V. Frangioni and B. G. Neel, Use of a general purpose mammalian expression vector for studying intracellular protein targeting: identification of critical residues in the nuclear lamin A/C nuclear localization signal, J Cell Sci. juin, vol.105, issue.2, pp.481-489, 1993.

N. Stuurman, S. Heins, and U. Aebi, Nuclear lamins: their structure, assembly, and interactions, J Struct Biol, vol.122, issue.1-2, pp.42-66, 1998.

L. Gerace and B. Burke, Functional organization of the nuclear envelope, Annu Rev Cell Biol, vol.4, pp.335-74, 1988.

G. Krohne and R. Benavente, The nuclear lamins. A multigene family of proteins in evolution and differentiation, Exp Cell Res. janv, vol.162, issue.1, pp.1-10, 1986.

E. A. Nigg, Assembly and cell cycle dynamics of the nuclear lamina, Semin Cell Biol. août, vol.3, issue.4, pp.245-53, 1992.

J. Irianto, C. R. Pfeifer, I. L. Ivanovska, J. Swift, and D. E. Discher, Nuclear lamins in cancer, Cell Mol Bioeng. juin, vol.9, issue.2, pp.258-67, 2016.

J. Swift, I. L. Ivanovska, A. Buxboim, T. Harada, P. Dingal et al., Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation, Science. 30 août, vol.341, issue.6149, p.1240104, 2013.

V. Butin-israeli, S. A. Adam, A. E. Goldman, and R. D. Goldman, Nuclear lamin functions and disease, Trends Genet. sept, vol.28, issue.9, pp.464-71, 2012.

J. Lammerding, P. C. Schulze, T. Takahashi, S. Kozlov, T. Sullivan et al., Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction, J Clin Invest. févr, vol.113, issue.3, pp.370-378, 2004.

J. Lammerding, L. G. Fong, J. Y. Ji, K. Reue, C. L. Stewart et al., Lamins A and C but not lamin B1 regulate nuclear mechanics, J Biol Chem. 1 sept, vol.281, issue.35, pp.25768-80, 2006.

R. Ungricht and U. Kutay, Mechanisms and functions of nuclear envelope remodelling, Nat Rev Mol Cell Biol. avr, vol.18, issue.4, pp.229-274, 2017.

A. B. Redwood, S. M. Perkins, R. P. Vanderwaal, Z. Feng, K. J. Biehl et al., A dual role for A-type lamins in DNA double-strand break repair, Cell Cycle. 1 août, vol.10, issue.15, pp.2549-60, 2011.

V. Butin-israeli, S. A. Adam, and R. D. Goldman, Regulation of nucleotide excision repair by nuclear lamin b1, PLoS ONE, vol.8, issue.7, p.69169, 2013.

R. Mahen, H. Hattori, M. Lee, P. Sharma, A. D. Jeyasekharan et al., A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei, PLoS ONE, vol.8, issue.5, p.61893, 2013.

J. Broers and F. Ramaekers, The role of the nuclear lamina in cancer and apoptosis, Adv Exp Med Biol, vol.773, pp.27-48, 2014.

N. Kubben and T. Misteli, Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases, Nat Rev Mol Cell Biol, vol.18, issue.10, pp.595-609, 2017.

D. Sandre-giovannoli, A. Bernard, R. Cau, P. Navarro, C. Amiel et al., Lamin a truncation in Hutchinson-Gilford progeria, Science. 27 juin, vol.300, issue.5628, p.2055, 2003.

M. Eriksson, W. T. Brown, L. B. Gordon, M. W. Glynn, J. Singer et al., Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome, Nature. 15 mai, vol.423, issue.6937, pp.293-301, 2003.

K. Harhouri, D. Frankel, C. Bartoli, P. Roll, D. Sandre-giovannoli et al., An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome, Nucleus. 1 janv, vol.9, issue.1, pp.246-57, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01774301

P. Fernandez, P. Scaffidi, E. Markert, J. Lee, S. Rane et al., Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4. Cell Rep, vol.9, pp.248-60, 2014.

C. D. Capo-chichi, K. Q. Cai, J. Smedberg, P. Ganjei-azar, A. K. Godwin et al., Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer, Chin J Cancer. juin, vol.30, issue.6, pp.415-440, 2011.

D. Zink, A. H. Fischer, and J. A. Nickerson, Nuclear structure in cancer cells, Nat Rev Cancer. sept, vol.4, issue.9, pp.677-87, 2004.

K. M. Sakthivel and P. Sehgal, A Novel Role of Lamins from Genetic Disease to Cancer Biomarkers, Oncol Rev, vol.10, issue.2, p.309, 2016.

E. Belt, R. Fijneman, E. G. Van-den-berg, H. Bril, P. M. Delis-van-diemen et al., Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence, Eur J Cancer. août, vol.47, issue.12, pp.1837-1882, 2011.

G. Gong, P. Chen, L. Li, H. Tan, J. Zhou et al., Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis, Pathol Res Pract. févr, vol.211, issue.2, pp.175-82, 2015.

A. Matsumoto, M. Hieda, Y. Yokoyama, Y. Nishioka, K. Yoshidome et al., Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer, Cancer Med. oct, vol.4, issue.10, pp.1547-57, 2015.

I. Saarinen, T. Mirtti, H. Seikkula, P. J. Boström, and P. Taimen, Differential Predictive Roles of A-and B-Type Nuclear Lamins in Prostate Cancer Progression, PLoS ONE, vol.10, issue.10, p.140671, 2015.

L. Kong, G. Schäfer, H. Bu, Y. Zhang, Y. Zhang et al., Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway, Carcinogenesis. avr, vol.33, issue.4, pp.751-760, 2012.

L. Cicchillitti, G. Corrado, M. Carosi, M. E. Dabrowska, R. Loria et al., Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer, Oncotarget. 31 janv, vol.8, issue.5, pp.7935-7980, 2017.

J. L. Broers, B. M. Machiels, H. J. Kuijpers, F. Smedts, R. Van-den-kieboom et al., A-and B-type lamins are differentially expressed in normal human tissues, Histochem Cell Biol. juin, vol.107, issue.6, pp.505-522, 1997.

S. H. Kaufmann, M. Mabry, R. Jasti, and J. H. Shaper, Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines, Cancer Res. 15 janv, vol.51, issue.2, pp.581-587, 1991.

J. L. Broers, Y. Raymond, M. K. Rot, H. Kuijpers, S. S. Wagenaar et al., Nuclear A-type lamins are differentially expressed in human lung cancer subtypes, Am J Pathol. juill, vol.143, issue.1, pp.211-231, 1993.

B. M. Machiels, J. L. Broers, Y. Raymond, L. De-ley, H. J. Kuijpers et al., Abnormal Atype lamin organization in a human lung carcinoma cell line, Eur J Cell Biol. août, vol.67, issue.4, pp.328-363, 1995.

E. Kaspi, D. Frankel, J. Guinde, S. Perrin, S. Laroumagne et al., Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status, PLoS ONE, vol.12, issue.8, p.183136, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01597882

G. Liao, M. Wang, Y. Ou, and Y. Zhao, IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1. Cell Signal, vol.26, pp.2131-2138, 2014.

S. Nath and P. Mukherjee, Muc1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol Med. juin, vol.20, issue.6, pp.332-374, 2014.

C. J. Hutchison and H. J. Worman, A-type lamins: guardians of the soma?, Nat Cell Biol, vol.6, issue.11, pp.1062-1069, 2004.

F. Guilak, J. R. Tedrow, and R. Burgkart, Viscoelastic properties of the cell nucleus, Biochem Biophys Res Commun. 24 mars, vol.269, issue.3, pp.781-787, 2000.

P. M. Davidson, J. Sliz, P. Isermann, C. Denais, and J. Lammerding, Design of a microfluidic device to quantify dynamic intra-nuclear deformation during cell migration through confining environments, Integr Biol (Camb). déc, vol.7, issue.12, pp.1534-1580, 2015.

M. Yabuki, T. Miyake, Y. Doi, T. Fujiwara, K. Hamazaki et al., Role of nuclear lamins in nuclear segmentation of human neutrophils, Physiol Chem Phys Med NMR, vol.31, issue.2, pp.77-84, 1999.

J. D. Pajerowski, K. N. Dahl, F. L. Zhong, P. J. Sammak, and D. E. Discher, Physical plasticity of the nucleus in stem cell differentiation, Proc Natl Acad Sci, vol.104, issue.40, pp.15619-15643, 2007.

C. Denais and J. Lammerding, Nuclear mechanics in cancer, Adv Exp Med Biol, vol.773, pp.435-70, 2014.

Q. Lu, Y. Yang, Y. S. Jin, Z. Zhang, D. Heber et al., Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration, Proteomics. févr, vol.9, issue.3, pp.757-67, 2009.

R. C. Lee, R. L. Feinbaum, and A. V. , The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell. 3 déc, vol.75, issue.5, pp.843-54, 1993.
URL : https://hal.archives-ouvertes.fr/in2p3-00597159

Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim et al., The nuclear RNase III Drosha initiates microRNA processing, Nature. 25 sept, vol.425, issue.6956, pp.415-424, 2003.

G. Hutvágner, J. Mclachlan, A. E. Pasquinelli, E. Bálint, T. Tuschl et al., A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA, Science. 3 août, vol.293, issue.5531, pp.834-842, 2001.

S. Jonas and E. Izaurralde, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet. juill, vol.16, issue.7, pp.421-454, 2015.

L. P. Lim, N. C. Lau, P. Garrett-engele, A. Grimson, J. M. Schelter et al., Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature. 17 févr, vol.433, issue.7027, pp.769-73, 2005.

A. Krek, D. Grün, M. N. Poy, R. Wolf, L. Rosenberg et al., Combinatorial microRNA target predictions, Nat Genet. mai, vol.37, issue.5, pp.495-500, 2005.

R. F. Place, L. Li, D. Pookot, E. J. Noonan, and R. Dahiya, MicroRNA-373 induces expression of genes with complementary promoter sequences, Proc Natl Acad Sci USA. 5 févr, vol.105, issue.5, pp.1608-1621, 2008.

A. Esquela-kerscher and F. J. Slack, Oncomirs -microRNAs with a role in cancer, Nat Rev Cancer. avr, vol.6, issue.4, pp.259-69, 2006.

M. S. Beg, A. J. Brenner, J. Sachdev, M. Borad, Y. Kang et al., Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors, Invest New Drugs, vol.35, issue.2, pp.180-188, 2017.

O. Slaby, R. Laga, and O. Sedlacek, Therapeutic targeting of non-coding RNAs in cancer, Biochem J. 14 déc, vol.474, issue.24, pp.4219-51, 2017.

G. Wilk and R. Braun, Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer, Nucleic Acids Res. 16 févr, vol.46, issue.3, pp.1089-101, 2018.

Z. Tian, S. Wen, Y. Zhang, X. Shi, Y. Zhu et al., Identification of dysregulated long noncoding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma, Oncotarget. 1 août, vol.8, issue.31, pp.51703-51721, 2017.

Y. Hsu, J. Hung, Y. Lee, F. Chen, C. Chang et al., Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis, Oncotarget. 1 déc, vol.8, issue.62, pp.104831-54, 2017.

A. Uddin and S. Chakraborty, Role of miRNAs in lung cancer, J Cell Physiol. 20 avr, 2018.

V. Senyuk, Y. Zhang, Y. Liu, M. Ming, K. Premanand et al., Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis, Proc Natl Acad Sci, vol.110, issue.14, pp.5594-5603, 2013.

A. Lujambio, G. A. Calin, A. Villanueva, S. Ropero, M. Sánchez-céspedes et al., A microRNA DNA methylation signature for human cancer metastasis, Proc Natl Acad Sci, vol.105, issue.36, pp.13556-61, 2008.

M. Sromek, M. Glogowski, M. Chechlinska, M. Kulinczak, L. Szafron et al., Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection, Cell Oncol (Dordr). 20 juin, 2017.

S. Volinia, G. A. Calin, C. Liu, S. Ambs, A. Cimmino et al., A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci, vol.103, issue.7, pp.2257-61, 2006.

M. Crawford, K. Batte, L. Yu, X. Wu, G. J. Nuovo et al., MicroRNA 133B targets prosurvival molecules MCL-1 and BCL2L2 in lung cancer, Biochem Biophys Res Commun, vol.388, issue.3, pp.483-492, 2009.

G. Heller, M. Weinzierl, C. Noll, V. Babinsky, B. Ziegler et al., Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers, Clin Cancer Res. 15 mars, vol.18, issue.6, pp.1619-1648, 2012.

R. Wang, X. Chen, and Y. Shu, Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics, Am J Cancer Res, vol.5, issue.1, pp.32-51, 2015.

T. Xu, X. Liu, L. Han, H. Shen, L. Liu et al., Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer, Clin Transl Oncol. mai, vol.16, issue.5, pp.469-75, 2014.

E. Polley, M. Kunkel, D. Evans, T. Silvers, R. Delosh et al., Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression, J Natl Cancer Inst, vol.108, issue.10, 2016.

X. Chen, L. Zhu, Z. Ma, G. Sun, X. Luo et al., Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep, vol.5, p.17031, 2015.

T. Muraoka, J. Soh, S. Toyooka, Y. Maki, K. Shien et al., Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers, Mol Clin Oncol. janv, vol.1, issue.1, pp.185-194, 2013.

J. Wang, B. Yang, L. Han, X. Li, H. Tao et al., Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines, Cell Physiol Biochem, vol.32, issue.6, pp.1707-1726, 2013.

J. M. Gwak, H. J. Kim, E. J. Kim, Y. R. Chung, S. Yun et al., MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer, Breast Cancer Res Treat. août, vol.147, issue.1, pp.39-49, 2014.

L. Ma, J. Young, H. Prabhala, E. Pan, P. Mestdagh et al., miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol. mars, vol.12, issue.3, pp.247-56, 2010.

S. J. Seashols-williams, W. Budd, G. C. Clark, Q. Wu, R. Daniel et al., miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis, PLoS ONE, vol.11, issue.7, p.159601, 2016.

Y. Song, J. Li, Y. Zhu, Y. Dai, T. Zeng et al., MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma, Oncotarget, vol.5, issue.22, pp.11669-80, 2014.

N. Yanaihara, Y. Noguchi, M. Saito, M. Takenaka, S. Takakura et al., MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma, PLoS ONE, vol.11, issue.9, p.162584, 2016.

G. Ding, Z. Peng, J. Shang, Y. Kang, H. Ning et al., LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism, Onco Targets Ther, vol.10, pp.3241-3248, 2017.

H. Wang, Q. Wu, Y. Zhang, H. Zhang, Y. Wang et al., TGF-?1-induced epithelialmesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin, Cell Mol Biol Lett, vol.22, p.22, 2017.

A. S. Yap, The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review, Cancer Invest, vol.16, issue.4, pp.252-61, 1998.

P. Cowin, T. M. Rowlands, and S. J. Hatsell, Cadherins and catenins in breast cancer, Curr Opin Cell Biol, vol.17, issue.5, pp.499-508, 2005.

D. Junghans, I. G. Haas, and R. Kemler, Mammalian cadherins and protocadherins: about cell death, synapses and processing, Curr Opin Cell Biol, vol.17, issue.5, pp.446-52, 2005.

U. H. Frixen, J. Behrens, M. Sachs, G. Eberle, B. Voss et al., E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells, J Cell Biol. avr, vol.113, issue.1, pp.173-85, 1991.

K. Vleminckx, L. Vakaet, M. Mareel, W. Fiers, and F. Van-roy, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell. 12 juill, vol.66, issue.1, pp.107-126, 1991.

A. K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori, A causal role for E-cadherin in the transition from adenoma to carcinoma, Nature. 12 mars, vol.392, issue.6672, pp.190-193, 1998.

P. Derksen, X. Liu, F. Saridin, H. Van-der-gulden, J. Zevenhoven et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell, vol.10, pp.437-486, 2006.

T. T. Onder, P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander et al., Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways, Cancer Res. 15 mai, vol.68, issue.10, pp.3645-54, 2008.

C. Fan, Y. Miao, X. Zhang, D. Liu, G. Jiang et al., Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer, BMC Cancer. 24 sept, vol.14, p.704, 2014.

G. Wang, W. Ma, Y. Li, Y. Jiang, G. Ma et al., Prognostic value of Twist, Snail and Ecadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study, Eur J Cardiothorac Surg. 5 févr, 2018.

K. W. Sinkevicius, K. J. Bellaria, J. Barrios, P. Pessina, M. Gupta et al., E-cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma, Am J Respir Cell Mol Biol. 15 févr, 2018.

E. Leucci, F. Patella, J. Waage, K. Holmstrøm, M. Lindow et al., microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus, Sci Rep, vol.3, p.2535, 2013.

T. Gutschner, M. Hämmerle, M. Eissmann, J. Hsu, Y. Kim et al., The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, Cancer Res. 1 févr, vol.73, issue.3, pp.1180-1189, 2013.

L. H. Schmidt, T. Spieker, S. Koschmieder, S. Schäffers, J. Humberg et al., The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth, J Thorac Oncol. déc, vol.6, issue.12, pp.1984-92, 2011.

L. Shen, L. Chen, Y. Wang, X. Jiang, H. Xia et al., Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer, J Neurooncol. janv, vol.121, issue.1, pp.101-109, 2015.

D. G. Weber, G. Johnen, S. Casjens, O. Bryk, B. Pesch et al., Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, BMC Res Notes. 6 déc, vol.6, p.518, 2013.

T. Gutschner, M. Hämmerle, and S. Diederichs, MALAT1 --a paradigm for long noncoding RNA function in cancer, J Mol Med. juill, vol.91, issue.7, pp.791-801, 2013.

H. Jung, C. Coffinier, Y. Choe, A. P. Beigneux, B. Davies et al., Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA, Proc Natl Acad Sci, vol.109, issue.7, pp.423-431, 2012.

X. Nissan, S. Blondel, C. Navarro, Y. Maury, C. Denis et al., Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neuralspecific miR-9 microRNA, Cell Rep. 26 juill, vol.2, issue.1, pp.1-9, 2012.

V. Tripathi, J. D. Ellis, Z. Shen, D. Y. Song, Q. Pan et al., The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Mol Cell. 24 sept, vol.39, issue.6, pp.925-963, 2010.

P. Scaffidi and T. Misteli, Lamin A-dependent nuclear defects in human aging, Science. 19 mai, vol.312, issue.5776, pp.1059-63, 2006.

R. Lin, M. Roychowdhury-saha, C. Black, A. T. Watt, E. G. Marcusson et al., Control of RNA processing by a large non-coding RNA over-expressed in carcinomas, FEBS Lett. 18 févr, vol.585, issue.4, pp.671-677, 2011.

S. Das and A. R. Krainer, Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer, Mol Cancer Res. sept, vol.12, issue.9, pp.1195-204, 2014.

M. Cohen-eliav, R. Golan-gerstl, S. Z. Andersen, C. L. Thorsen, K. Ørntoft et al., The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers, J Pathol. mars, vol.229, issue.4, pp.630-639, 2013.

S. Gout, E. Brambilla, A. Boudria, R. Drissi, S. Lantuejoul et al., Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma, PLoS ONE, vol.7, issue.10, p.46539, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02337424

K. R. Fischer, A. Durrans, S. Lee, J. Sheng, F. Li et al., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, vol.527, issue.7579, pp.472-478, 2015.

X. Zheng, J. L. Carstens, J. Kim, M. Scheible, J. Kaye et al., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, vol.527, issue.7579, pp.525-555, 2015.